Literature DB >> 15327379

Epidemiologic data of primary glomerular diseases in western France.

Pierre Simon1, Marie-Paule Ramee, Rehouni Boulahrouz, Corina Stanescu, Christophe Charasse, Kim Seng Ang, Françoise Leonetti, Gérard Cam, Eric Laruelle, Valérie Autuly, Nathalie Rioux.   

Abstract

Between January 1, 1976, and December 31, 2002, histologic diagnosis of primary glomerular diseases (PGD) was made in 898 patients born and living at the time of diagnosis in a region of France, comprising 412,735 inhabitants, of whom 391,265 were aged from 10 to 85 years. The prevalence of PGD during a 75-year exposure to risk (10 to 85 years of age) was evaluated to 6.9 in 1000 (8.2 in 1000 males and 5.1 in 1000 females) during the 27-year period. The most common PGD was IgA nephropathy (IgAN) with a prevalence of 2.4 in 1000 (3.6 in 1000 males and 1.3 in 1000 females). The annual incidence of PGD was evaluated separately for two consecutive 10-years periods: period A (1976 to 1985), period B (1986 to 1995) and for one 7-year period: period C (1996 to 2002). Within each of these three periods, annual incidence of PGD was 89, 76, and 65 per million inhabitants. During this 27-year period, the annual incidences of membranoproliferative glomerulonephritis (GN) and membranous nephropathy were declining and the incidence of crescentic proliferative GN was strongly progressing, whereas annual incidence of nephrosis remained stable. The incidence of IgAN remained the same throughout the three periods: 28, 28, and 26 per million inhabitants. Whereas the incidence of IgAN was three- to fourfold higher in the adult aged from 20 to 59 years than in the elderly during the periods A (38 vs. 11 per million inhabitants) and B (37 vs. 12 per million inhabitants), the incidence became similar whatever age groups during the last period C (20 to 59 years, 25 per million inhabitants; 60 to 79 years, 27 per million inhabitants; and 80 years and over, 28 per million inhabitants. The stability of annual incidence according to period and age, which is demonstrated for the first time during the last period, provides a new evidence of a role for genetic factors in the pathogenesis of IgAN.

Entities:  

Mesh:

Year:  2004        PMID: 15327379     DOI: 10.1111/j.1523-1755.2004.00834.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  62 in total

1.  Adalimumab-induced IgA nephropathy.

Authors:  Aneesha Kaur Bhagat Singh; Andrew Sujeevan Jeyaruban; Gregory John Wilson; Dwarakanathan Ranganathan
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011.

Authors:  Dita Maixnerova; Eva Jancova; Jelena Skibova; Romana Rysava; Ivan Rychlik; Ondrej Viklicky; Miroslav Merta; Alexander Kolsky; Jana Reiterova; Michaela Neprasova; Jana Kidorova; Eva Honsova; Vladimir Tesar
Journal:  J Nephrol       Date:  2014-04-23       Impact factor: 3.902

3.  A 5-year survey of biopsy proven kidney diseases in Lebanon: significant variation in prevalence of primary glomerular diseases by age, population structure and consanguinity.

Authors:  Hussein H Karnib; Ali G Gharavi; Georges Aftimos; Ziyad Mahfoud; Reem Saad; Elias Gemayel; Badiaa Masri; Shafika Assaad; Kamal F Badr; Fuad N Ziyadeh
Journal:  Nephrol Dial Transplant       Date:  2010-06-04       Impact factor: 5.992

4.  Significance of broad distribution of electron-dense deposits in patients with IgA nephropathy.

Authors:  Gaku Kusaba; Isao Ohsawa; Masaya Ishii; Hiroyuki Inoshita; Miyuki Takagi; Chiaki Tanifuji; Kaori Takahashi; Junichi Nakamoto; Mitsutaka Yoshida; Hiroyuki Ohi; Satoshi Horikoshi; Hidetake Kurihara; Yasuhiko Tomino
Journal:  Med Mol Morphol       Date:  2012-03-20       Impact factor: 2.309

5.  Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010.

Authors:  Hitoshi Sugiyama; Hitoshi Yokoyama; Hiroshi Sato; Takao Saito; Yukimasa Kohda; Shinichi Nishi; Kazuhiko Tsuruya; Hideyasu Kiyomoto; Hiroyuki Iida; Tamaki Sasaki; Makoto Higuchi; Motoshi Hattori; Kazumasa Oka; Shoji Kagami; Tetsuya Kawamura; Tetsuro Takeda; Hiroshi Hataya; Yuichiro Fukasawa; Atsushi Fukatsu; Kunio Morozumi; Norishige Yoshikawa; Akira Shimizu; Hiroshi Kitamura; Yukio Yuzawa; Seiichi Matsuo; Yutaka Kiyohara; Kensuke Joh; Michio Nagata; Takashi Taguchi; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2013-02-06       Impact factor: 2.801

6.  Role of activated intrarenal reactive oxygen species and renin-angiotensin system in IgA nephropathy model mice.

Authors:  Naro Ohashi; Akemi Katsurada; Kayoko Miyata; Ryousuke Satou; Toshie Saito; Maki Urushihara; Hiroyuki Kobori
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-03-02       Impact factor: 2.557

7.  Epidemiologic data of adult native biopsy-proven renal diseases in Croatia.

Authors:  Ivica Horvatic; Miroslav Tisljar; Stela Bulimbasic; Borka Bozic; Danica Galesic Ljubanovic; Kresimir Galesic
Journal:  Int Urol Nephrol       Date:  2013-03-01       Impact factor: 2.370

8.  Renal biopsy findings in acute renal failure in the cohort of patients in the Spanish Registry of Glomerulonephritis.

Authors:  Juan M López-Gómez; Francisco Rivera
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 8.237

9.  Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.

Authors:  Hiroyuki Kobori; Akemi Katsurada; Yuri Ozawa; Ryousuke Satou; Kayoko Miyata; Naoki Hase; Yuki Suzaki; Tatsuya Shoji
Journal:  Biochem Biophys Res Commun       Date:  2007-04-26       Impact factor: 3.575

10.  A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study.

Authors:  Masashi Goto; Kenji Wakai; Takashi Kawamura; Masahiko Ando; Masayuki Endoh; Yasuhiko Tomino
Journal:  Nephrol Dial Transplant       Date:  2009-06-10       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.